Biopharmaceutical companies face multiple external pressures. Shareholders demand a profitable company while governments, nongovernmental third parties, and the public at large expect a commitment to improving health in developed and, in particular, emerging economies. This purpose of this article was to define a conceptual framework and build an analytic decision-making tool to assess and enhance a company’s global portfolio while balancing its business needs with broader social expectations. Read more now. (Source: Elsevier, Value In Health 17).
You are here: / / Biopharmaceutical Companies – Balancing Business Needs With Social Expectations